Autolus Therapeutics plc American Depositary Share (NASDAQ: AUTL) last traded at $1.81, up 2.26% on the session. The quote above updates while this page is open; the figures below are drawn from Autolus Therapeutics plc American Depositary Share’s own filings and are restated only when a new one is published.
Autolus Therapeutics plc American Depositary Share trades on NASDAQ under the ticker AUTL. Its market capitalisation is $481.75 million.
Valuation measures for Autolus Therapeutics plc American Depositary Share, derived from the latest quote and its most recent SEC filing.
| Market cap | $481.75M |
|---|---|
| Enterprise value | $728.73M |
| Price / sales | 4.10 |
| Price / book | 6.44 |
| Beta | 1.79 |
Trailing-twelve-month figures tagged in Autolus Therapeutics plc American Depositary Share's XBRL filings with the SEC.
| Revenue (TTM) | $117.39M |
|---|---|
| Net income (TTM) | -$280.16M |
| EPS (TTM) | -$1.06 |
| Gross margin | 15.66% |
| Operating margin | -210.78% |
| Return on equity | -374.35% |
| Cash | $171.41M |
Range and volume for AUTL over the past 52 weeks.
| 52-week high | $2.58 |
|---|---|
| 52-week low | $1.18 |
| Volume | 1.48M |
| Average volume | 2.09M |
| Previous close | $1.77 |
Invest a chosen dollar amount in Autolus Therapeutics plc American Depositary Share with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AUTL.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.